financetom
Business
financetom
/
Business
/
Senators question Paramount's Redstone over '60 Minutes' settlement attempts with Trump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Senators question Paramount's Redstone over '60 Minutes' settlement attempts with Trump
May 26, 2025 10:58 AM

(Reuters) -A group of senators sent a letter to Paramount Global chair Shari Redstone on Monday, seeking information about the CBS News owner's efforts to settle a lawsuit with U.S. President Donald Trump.

Senators Elizabeth Warren, Bernie Sanders and Ron Wyden are questioning whether Paramount's potential attempts to resolve the high profile lawsuit could violate federal anti-bribery laws, according to the letter seen by Reuters.

CBS News faces a $20 billion lawsuit from Trump over its editing of a "60 Minutes" interview in October 2024 with then-Democratic presidential candidate Kamala Harris.

This lawsuit is seen as a major roadblock to the Paramount and Skydance Media merger, according to some analysts.

Paramount has also entered mediation in April to try and settle the lawsuit. The $8.4 billion merger requires approval from the U.S. Federal Communications Commission.

The federal agency has authority over the transaction because it needs to approve the transfer of the broadcast television licenses held by CBS. The deal was extended for 90 days, as the companies await regulatory approval.

A spokesperson for Paramount Global declined to comment on the letter but has previously said that the "lawsuit is completely separate from, and unrelated to, the Skydance transaction and the FCC (Federal Communications Commission) approval process."

Meanwhile, CBS News President and Chief Executive Wendy McMahon is stepping down from her position, telling staffers that she and the company have differing views on the path forward.

Bill Owens, the network's long-time executive producer of "60 Minutes," also announced his departure over editorial independence concerns.

"Paramount appears to have begun overseeing CBS's content, presumably in order to screen it for content that could anger the Trump Administration," the letter said. A spokesperson for Redstone also declined to comment.

The Wall Street Journal was the first to report the news.

(Reporting by Jaspreet Singh in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Nov 20, 2025
Vanda Pharmaceuticals Inc. ( VNDA ) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Novo Nordisk A/S ( NVO ) Wegovy. • Get the market research on VNDA stock here. The trial studied 116 healthy overweight or obese adults. The study saw 29.3% of tradipitant-treated participants (17/58)...
Stifel Canada on Role of Defence Investments For MDA
Stifel Canada on Role of Defence Investments For MDA
Nov 20, 2025
01:56 PM EST, 11/20/2025 (MT Newswires) -- This week, industry minister Melanie Joly said Canada will invest $529 million in the European Space Agency (ESA) for the advancement of R&D of Canadian space technologies. This announcement directly supports our Defence investment thesis on MDA, writes Stifel Canada analyst Greg MacDonald. In our view, Defence policy is now Industrial policy and...
Medexus Pharmaceuticals to Launch Normal Course Issuer Bid
Medexus Pharmaceuticals to Launch Normal Course Issuer Bid
Nov 20, 2025
01:58 PM EST, 11/20/2025 (MT Newswires) -- Medexus Pharmaceuticals ( MEDXF ) on Thursday said it received exchange approvals to launch a normal course issuer bid (NCIB).. The company may buy back for cancellation up to 2.98-million shares, about 10% of the public float. As of Nov. 12, the company had 32.4-million shares outstanding and a public float of 29.8-million...
Provident Healthcare Partners Advises Meperia in its Acquisition by Diversis Capital
Provident Healthcare Partners Advises Meperia in its Acquisition by Diversis Capital
Nov 20, 2025
BOSTON, Nov. 20, 2025 /PRNewswire/ -- Provident Healthcare Partners (Provident), a leading healthcare investment banking firm, is pleased to announce it has advised Meperia, a supply chain and strategic sourcing platform serving Integrated Delivery Networks (IDNs). Provident also facilitated Diversis in the acquisition of Kermit, a bill-only, spend management, and analytics platform for physician preference items (PPI). This transaction marks...
Copyright 2023-2026 - www.financetom.com All Rights Reserved